<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 01 Jun 2021 07:47:13 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>什么是新药的“有条件批准上市”？</title><link>https://mp.weixin.qq.com/s/lC1FCQ5z4ezCysriATpQhg</link><description></description><content:encoded><![CDATA[什么是新药的“有条件批准上市”？]]></content:encoded><pubDate>Mon, 31 May 2021 19:51:47 +0800</pubDate></item><item><title>CDE部长杨志敏等专家解答，药品申报注册18 问及注册生产现场检查流程</title><link>https://mp.weixin.qq.com/s/KnXMR-_udPZZLeTiVntCog</link><description></description><content:encoded><![CDATA[CDE部长杨志敏等专家解答，药品申报注册18 问及注册生产现场检查流程]]></content:encoded><pubDate>Mon, 31 May 2021 19:51:47 +0800</pubDate></item><item><title>首个国产一线肝细胞癌靶向药物即将获批上市</title><link>https://mp.weixin.qq.com/s/TnPeagA95q81wBZrwpJTYg</link><description></description><content:encoded><![CDATA[首个国产一线肝细胞癌靶向药物即将获批上市]]></content:encoded><pubDate>Mon, 31 May 2021 19:51:47 +0800</pubDate></item><item><title>中英文 ICH-Q8,Q9,Q10 课件ppt</title><link>https://mp.weixin.qq.com/s/-U9t2Z3hXe4bYSmfzE2CDg</link><description></description><content:encoded><![CDATA[中英文 ICH-Q8,Q9,Q10 课件ppt]]></content:encoded><pubDate>Mon, 31 May 2021 19:51:47 +0800</pubDate></item><item><title>严重副作用不同疾病的对应手册（面向患者·公众）（63）-惊厥、癫痫</title><link>https://mp.weixin.qq.com/s/Ysk7dK2nyt9X-IPgPtNipA</link><description></description><content:encoded><![CDATA[严重副作用不同疾病的对应手册（面向患者·公众）（63）-惊厥、癫痫]]></content:encoded><pubDate>Sun, 30 May 2021 21:15:54 +0800</pubDate></item><item><title>中检院：药品注册检验送检须知</title><link>https://mp.weixin.qq.com/s/fyLcRZo7aCDSLGDFmx2Fkw</link><description></description><content:encoded><![CDATA[中检院：药品注册检验送检须知]]></content:encoded><pubDate>Sun, 30 May 2021 21:15:54 +0800</pubDate></item><item><title>CDE专家解析《药品注册管理办法》</title><link>https://mp.weixin.qq.com/s/_6n0v8Bv18dg5THTjI848Q</link><description></description><content:encoded><![CDATA[CDE专家解析《药品注册管理办法》]]></content:encoded><pubDate>Sun, 30 May 2021 21:15:54 +0800</pubDate></item><item><title>《药品检查管理办法（试行）》发布</title><link>https://mp.weixin.qq.com/s/0isRMc8YAmr4BV4h-hJsXA</link><description></description><content:encoded><![CDATA[《药品检查管理办法（试行）》发布]]></content:encoded><pubDate>Sat, 29 May 2021 19:47:30 +0800</pubDate></item><item><title>PD-1/PD-L1 抑制剂的剂量选择与优化</title><link>https://mp.weixin.qq.com/s/FJd_xerZOaB5AR189GT6NA</link><description></description><content:encoded><![CDATA[PD-1/PD-L1 抑制剂的剂量选择与优化]]></content:encoded><pubDate>Sat, 29 May 2021 19:47:30 +0800</pubDate></item><item><title>一文理清！最全肿瘤标志物解读！</title><link>https://mp.weixin.qq.com/s/_swb6AeS2GUlvbuqFXD3_g</link><description></description><content:encoded><![CDATA[一文理清！最全肿瘤标志物解读！]]></content:encoded><pubDate>Sat, 29 May 2021 19:47:30 +0800</pubDate></item><item><title>重磅！全球首个新冠灭活疫苗Ⅲ期临床数据正式发表</title><link>https://mp.weixin.qq.com/s/uXCJSJLKobz61_gvzHeJiw</link><description></description><content:encoded><![CDATA[重磅！全球首个新冠灭活疫苗Ⅲ期临床数据正式发表]]></content:encoded><pubDate>Fri, 28 May 2021 08:00:25 +0800</pubDate></item><item><title>NMPA发布：执业药师电子注册证来了，长这样</title><link>https://mp.weixin.qq.com/s/Uo4OF7ezxahLDM3vH536FQ</link><description></description><content:encoded><![CDATA[NMPA发布：执业药师电子注册证来了，长这样]]></content:encoded><pubDate>Fri, 28 May 2021 08:00:25 +0800</pubDate></item><item><title>深度解读：后新冠时代，疫苗研发未来可期（内含福利）</title><link>https://mp.weixin.qq.com/s/M0XL03g1Ul0B44HaRvKFJQ</link><description></description><content:encoded><![CDATA[深度解读：后新冠时代，疫苗研发未来可期（内含福利）]]></content:encoded><pubDate>Fri, 28 May 2021 08:00:25 +0800</pubDate></item><item><title>药典委关于2020年版药典相关问题的解读（一）</title><link>https://mp.weixin.qq.com/s/fj8quovXI3SAs2Zk3Suzzg</link><description></description><content:encoded><![CDATA[药典委关于2020年版药典相关问题的解读（一）]]></content:encoded><pubDate>Fri, 28 May 2021 08:00:25 +0800</pubDate></item><item><title>原料药中稳定性试验应该怎么做？</title><link>https://mp.weixin.qq.com/s/kMyiyOBUqZkvpGbhWH1phg</link><description></description><content:encoded><![CDATA[原料药中稳定性试验应该怎么做？]]></content:encoded><pubDate>Wed, 26 May 2021 21:38:37 +0800</pubDate></item><item><title>【DIA好声音】抗肿瘤联合用药开发策略考量</title><link>https://mp.weixin.qq.com/s/WXYVr2XSokv39-WklUCudQ</link><description></description><content:encoded><![CDATA[【DIA好声音】抗肿瘤联合用药开发策略考量]]></content:encoded><pubDate>Wed, 26 May 2021 21:38:37 +0800</pubDate></item><item><title>国外药品审评专家咨询制度在药品审评体系中的作用及思考</title><link>https://mp.weixin.qq.com/s/qFF2HzUGHRA9KErAL_hhvQ</link><description></description><content:encoded><![CDATA[国外药品审评专家咨询制度在药品审评体系中的作用及思考]]></content:encoded><pubDate>Wed, 26 May 2021 21:38:37 +0800</pubDate></item><item><title>肺癌抗血管生成药物大盘点</title><link>https://mp.weixin.qq.com/s/TXGj-JXd57fk-mPQJfUl9w</link><description></description><content:encoded><![CDATA[肺癌抗血管生成药物大盘点]]></content:encoded><pubDate>Tue, 25 May 2021 21:33:27 +0800</pubDate></item><item><title>一文讲透美国DMF</title><link>https://mp.weixin.qq.com/s/ZhnGHxZZXPLynRk9kmTmnA</link><description></description><content:encoded><![CDATA[一文讲透美国DMF]]></content:encoded><pubDate>Tue, 25 May 2021 21:33:27 +0800</pubDate></item><item><title>什么是生物制品批签发？</title><link>https://mp.weixin.qq.com/s/B-bvUCtQBP9l86dVFXayLw</link><description></description><content:encoded><![CDATA[什么是生物制品批签发？]]></content:encoded><pubDate>Tue, 25 May 2021 21:33:27 +0800</pubDate></item></channel></rss>